ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Avista Pharma Solutions has doubled active pharmaceutical ingredient (API) production capacity at its Longmont, Colo., site. As part of the project, the company upgraded three API manufacturing suites and added a fourth. Avista was formed in 2015 when Ampersand Capital Partners combined Array BioPharma’s chemistry facility in Longmont with Scynexis’s contract R&D assets in Research Triangle Park, N.C., and Accuratus Lab Services in Eagan, Minn.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X